Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel.

J Clin Pathol. 1985 February; 38(2): 165–173.

PMCID: PMC499097

H B Coakham, J A Garson, P M Allan, E I Harper, B Brownell, J T Kemshead, and E B Lane

This article has been cited by other articles in PMC.

Abstract

A panel of seven monoclonal antibodies has been used to characterise 164 cerebral and spinal tumours. These reagents have enabled rapid and accurate diagnosis of tumours to be made, particularly in cases where standard techniques have proved equivocal. On the basis of characteristic antigenic profiles of tumours, it has been possible to distinguish between gliomas, meningiomas, schwannomas, medulloblastomas, neuroblastomas, choroid plexus tumours, various metastatic deposits, and primary brain lymphomas. The reagents used in the study comprise antibodies binding to (a) most neuroectodermally derived tissues and tumours (UJ13A), (b) fetal brain and tumours of neuroblastic origin (UJ181.4), (c) schwannomas, normal and neoplastic neurones (UJ127.11), (d) glial cells (FD19), (e) epithelial cells (LE61), and (f) leucocytes (2D1). Some reagents, such as antibody A2B5, were less effective as diagnostic markers than originally suggested by previously described specificity. This monoclonal antibody reacted with both neuroectodermal and epithelial derived tumours. The panel of monoclonal antibodies was most useful in the diagnosis of tumours composed of small round cells, particularly lymphoma and neuroblastoma, but the pattern of reactivities allowed most of the central nervous system tumours to be accurately classified. This approach was a valuable adjunct to conventional histological techniques in about 20% of the cases examined.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Köhler, G; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. [PubMed]
Allan, PM; Garson, JA; Harper, EI; Asser, U; Coakham, HB; Brownell, B; Kemshead, JT. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. [PubMed]
Kemshead, JT; Fritschy, J; Garson, JA; Allan, P; Coakham, H; Brown, S; Asser, U. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer. 1983 Feb 15;31(2):187–195. [PubMed]
Lane, EB. Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J Cell Biol. 1982 Mar;92(3):665–673. [PubMed]
Eisenbarth, GS; Walsh, FS; Nirenberg, M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4913–4917. [PubMed]
van der Meulen, JD; Houthoff, HJ; Ebels, EJ. Glial fibrillary acidic protein in human gliomas. Neuropathol Appl Neurobiol. 1978 4(3):177–190.May–Jun; [PubMed]
Velasco, ME; Dahl, D; Roessmann, U; Gambetti, P. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer. 1980 Feb;45(3):484–494. [PubMed]
Camins, MB; Cravioto, HM; Epstein, F; Ransohoff, J. Medulloblastoma: an ultrastructural study--evidence for astrocytic and neuronal differentiation. Neurosurgery. 1980 Apr;6(4):398–411. [PubMed]
Bignami, A; Eng, LF; Dahl, D; Uyeda, CT. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 1972 Aug 25;43(2):429–435. [PubMed]
Ghadially, FN. The role of electron microscopy in the determination of tumour histogenesis. Diagn Histopathol. 1981 4(3):245–262.Jul–Sep; [PubMed]
Gatter, KC; Abdulaziz, Z; Beverley, P; Corvalan, JR; Ford, C; Lane, EB; Mota, M; Nash, JR; Pulford, K; Stein, H; Taylor-Papadimitriou, J; Woodhouse, C; Mason, DY. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. [PubMed]
Trojanowski, JQ; Lee, VM. Monoclonal and polyclonal antibodies against neural antigens: diagnostic applications for studies of central and peripheral nervous system tumors. Hum Pathol. 1983 Apr;14(4):281–285. [PubMed]
Garson, JA; Beverley, PC; Coakham, HB; Harper, EI. Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature. 1982 Jul 22;298(5872):375–377. [PubMed]
Kemshead, JT; Jones, DH; Goldman, A; Richardson, RB; Coakham, HB. Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper. J R Soc Med. 1984 Oct;77(10):847–854. [PubMed]
Warnke, RA; Gatter, KC; Falini, B; Hildreth, P; Woolston, RE; Pulford, K; Cordell, JL; Cohen, B; De Wolf-Peeters, C; Mason, DY. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med. 1983 Nov 24;309(21):1275–1281. [PubMed]
Makin, CA; Bobrow, LG; Bodmer, WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. [PubMed]
Coakham, HB; Garson, JA; Brownell, B; Allan, PM; Harper, EI; Lane, EB; Kemshead, JT. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet. 1984 May 19;1(8386):1095–1098. [PubMed]
Arklie, J; Taylor-Papadimitrious, J; Bodmer, W; Egan, M; Millis, R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer. 1981 Jul 15;28(1):23–29. [PubMed]